2023
DOI: 10.1038/s41434-023-00403-3
|View full text |Cite
|
Sign up to set email alerts
|

Repeat or single-dose lentiviral vector administration to mouse lungs? It’s all about the timing

Abstract: Lentiviral vectors are attractive delivery vehicles for cystic fibrosis gene therapy owing to their low immunogenicity and ability to integrate into the host cell genome, thereby producing long-term, stable gene expression. Nonetheless, repeat dosing may be required to increase initial expression levels, and/or boost levels when they wane. The primary aim of this study was to determine if repeat dosing of a VSV-G pseudotyped LV vector delivered into mouse lungs is more effective than a single dose. C57Bl/6 mou… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 28 publications
0
1
0
Order By: Relevance
“…Recent efforts in lentiviral drug development, including dosing strategies, continue to support increasing promise. Using luciferase bioluminescence as an efficacy read-out, Donnelley et al recently administered a lentiviral vector to murine lungs, either as a single dose, or by split dosing in which smaller amounts were delivered repeatedly at various intervals [18]. Higher bioluminescence flux was achieved if the dose was split into two sub-doses a day apart, but extra splitting had no significant additional benefit.…”
Section: Lentivirus Vector Gene Deliverymentioning
confidence: 99%
“…Recent efforts in lentiviral drug development, including dosing strategies, continue to support increasing promise. Using luciferase bioluminescence as an efficacy read-out, Donnelley et al recently administered a lentiviral vector to murine lungs, either as a single dose, or by split dosing in which smaller amounts were delivered repeatedly at various intervals [18]. Higher bioluminescence flux was achieved if the dose was split into two sub-doses a day apart, but extra splitting had no significant additional benefit.…”
Section: Lentivirus Vector Gene Deliverymentioning
confidence: 99%